News
Immunoglobulin A nephropathy (IgAN), or Berger’s disease, is a chronic kidney disorder characterized by deposition of IgA antibodies in the glomeruli, which leads to inflammation and progressive renal ...
A possible magnitude-nine earthquake along the Nankai Trough, a submarine trough near the South of Japan, may lead to up to 298,000 deaths and a loss of up to 270 trillion yen (S$2.43 trillion ...
Sickle cell disease affects millions of children every year, many of them African American. Keep yourself, family and loved ones healthy by knowing and sharing the facts. In the United States, most ...
nhs.net Objectives To develop patient-reported experience measure surveys for patients with sickle cell disease (SCD) to understand their healthcare and lived experience in the UK and for their use in ...
Sickle cell disease (SCD) is a series of genetic blood abnormalities. Due to hemoglobin damage, your red blood cells (RBCs) lose their adaptable donut shape and adopt a "C" shape. These cells become ...
NBC News on MSN14d
CDC cuts spark fears for women with sickle cell diseaseA Michigan woman living with sickle cell disease says her life may now be at risk after the CDC disbanded the team responsible for researching safe birth control for people with chronic conditions ...
Why are these precautions important for people with sickle cell disease? What summer activities should be avoided if you have sickle cell disease?
Sickle Cell Anaemia causes crescent-shaped red blood cells, blocking blood flow and causing painful crises Key symptoms include hand-foot syndrome, acute chest syndrome, vision problems, and stroke ...
A Michigan woman living with sickle cell disease says her life may now be at risk after the CDC disbanded the team responsible for researching safe birth control for people with chronic conditions ...
Rilzabrutinib is an investigational, oral, reversible Bruton tyrosine kinase inhibitor. The Food and Drug Administration (FDA) has granted Orphan Drug designation to rilzabrutinib for the ...
The FDA has granted orphan drug status to rilzabrutinib, an investigational therapy to prevent pain crises in sickle cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results